רמיפריל טבע 5 מג
teva pharmaceutical industries ltd, israel - ramipril - טבליה - ramipril 5 mg - ramipril - ramipril - - hypertension - congestive heart failure - reduction of mortality in patients after mi with left ventricular dysfunction for reducing the risk of myocardial infarction stoke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous mi unstable angina or multivessel cabg or multivessel ptca) stroke or peripheral vascular disease. also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmhg or diastolic pressure > 90 mmhg) high total cholesterol (>5.2 mmol/l) low hdl ( <0.9 mmol/l) current smoker known microalbuminuria clinical evidence of previous vascular disease. - prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.
רמיטנס 10
rafa laboratories ltd - ramipril - קפסולות - ramipril 10 mg - ramipril - ramipril - hypertension congestive heart failure reduction of mortality in patients after mi with left ventricular dysfunction. for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous mi unstable angina or multivessel cabg or multivessel ptca) stroke or peripheral vascular disease. also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmhg or diastolic pressure > 90 mmhg) high total cholesterol (>5.2 mmol/l) low hdl ( <0.9 mmol/l) current smoker known microalbuminuria clinical evidence of previous vascular disease. prevention of progressive renal failure in patients suffering from impaired renal function.
וזודיפ קומבו 10
dexcel ltd, israel - enalapril maleate; lercanidipine hydrochloride - טבליה - lercanidipine hydrochloride 10 mg; enalapril maleate 10 mg - enalapril - enalapril - treatment of essential hypertension in whose blood pressure cannot be adequately controlled under lercanidipine monotherapy.
סילריל 1
unipharm ltd, israel - cilazapril - טבליה - cilazapril 1 mg - cilazapril
סילריל 2.5
unipharm ltd, israel - cilazapril - טבליה - cilazapril 2.5 mg - cilazapril
סילריל 5
unipharm ltd, israel - cilazapril - טבליה - cilazapril 5 mg - cilazapril
סילאזפריל פלוס טבע
teva pharmaceutical industries ltd, israel - cilazapril as monohydrate; hydrochlorothiazide - טבליה - cilazapril as monohydrate 5 mg; hydrochlorothiazide 12.5 mg - cilazapril - cilazapril - treatment of essential hypertension in patients who have been stabilized on the individual components given in the same proportions.
אנלדקס 5 מג
dexcel ltd, israel - enalapril maleate - טבליה - enalapril maleate 5 mg - enalapril - enalapril - treatment of essential hypertension, renovascular hypertension congestive heart failure and to reduce mortality in patients with all degrees of heart failure. to retard the development of symptomatic heart failure in asymptomatic patients with left ventricular dysfunction.
אנלדקס 10 מג
dexcel ltd, israel - enalapril maleate - טבליה - enalapril maleate 10 mg - enalapril - enalapril - treatment of essntial hypertension, renovascular hypertension congestive heart failure and to reduce mortality in patients with all degrees of heart failure. to retard the development of symptomatic heart failure in asymptomatic patients with left ventricular dysfunction.
אנלדקס 20 מג
dexcel ltd, israel - enalapril maleate - טבליה - enalapril maleate 20 mg - enalapril - enalapril - treatment of essential hypertension, renovascular hypertension congestive heart failure and to reduce mortality in patients with all degrees of heart failure. to retard the development of symptomatic heart failure in asymptomatic patients with left ventricular dysfunction.